-
MIAMI -- Answerthink, Inc. (NASDAQ: ANSR), announced today the successful go-live of EzMed, an SAP All-in-One business software solution, at Abiomed, ...
-
DANVERS, Mass. -- Abiomed, Inc. (NASDAQ: ABMD) today announced the public offering of 2,419,932 shares of its common stock. Morgan Stanley & Co. Incor...
-
DANVERS, Mass. -- Abiomed, Inc. (NASDAQ: ABMD) today announced plans to offer 5,000,000 shares of its common stock in an underwritten public offering ...
-
PALO ALTO, Calif. -- ABIOMED Recognized for Innovative Products Ranging From Bridge to Recovery to Destination Therapy
In its recent analysis, Frost...
-
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79572) has announced the addition of "ABIOMED, Inc. Strategic Anal...
-
DANVERS, Mass. -- Abiomed, Inc. (NASDAQ: ABMD) today announced that it has priced its offering of common stock at $13.75 per share. The offering consi...
-
DANVERS, Mass. -- Abiomed, Inc. (NASDAQ: ABMD) today confirmed its fiscal year 2009 revenue guidance of $75 - 80 million.
Abiomed will be announcing...
-
DANVERS, Mass. -- Abiomed, Inc. (NASDAQ: ABMD) today announced the completion of the public offering of 5,000,000 shares of its common stock at $13.75...
-
BOSTON -- Abiomed Inc.
WHAT: Abiomed Inc. names Tufts-New England Medical Center (Tufts-NEMC) of Boston as a Center of Excellence for recovery of th...
-
DANVERS, Mass. -- Abiomed, Inc. (NASDAQ: ABMD) today announced the completion of the public offering of 2,419,932 shares of its common stock at $17.37...